Page last updated: 2024-08-25

s20098 and Long Sleeper Syndrome

s20098 has been researched along with Long Sleeper Syndrome in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (3.70)18.2507
2000's10 (37.04)29.6817
2010's16 (59.26)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballester, P; Belda, C; Fernández, E; Inda, MD; Javaloyes, A; Martínez, MJ; Morales, D; Muriel, J; Peiró, AM; Richdale, AL; Toral, N1
Deuschle, M; Fischer, EC; Zapp, AA1
Grosshans, M; Kiefer, F; Mutschler, J1
Frydman-Marom, A; Laudon, M1
Campanella, D; De Bartolomeis, A; De Berardis, D; Di Giannantonio, M; Di Nicola, M; Fornaro, M; Iasevoli, F; Martinotti, G; Mazza, M; Olivieri, L; Perna, G; Rapini, G; Serroni, N; Srinivasan, V; Tomasetti, C; Valchera, A1
Bucci, N; Perugi, G; Quaranta, G1
Avila, A; Bello, J; Caballol, N; Cardona, X; Leon, L; Martin-Baranera, M; Millet, P1
Dressman, MA; McLin, DE; Neubauer, DN; Williams, WP1
Cardinali, DP; Hardeland, R; Pandi-Perumal, SR; Poeggeler, B; Spence, DW; Srinivasan, V; Trakht, I1
Brown, GM; Cardinali, DP; Moscovitch, A; Pandi-Perumal, SR; Spence, DW; Srinivasan, V1
Popoli, M1
Kennedy, SH1
Kálmán, J; Kálmán, S1
Mendlewicz, J1
Owen, RT1
Guilleminault, C; Lemoine, P; Quera-Salva, MA1
Howland, RH1
Catalani, A; Cianci, S; Consolazione, M; Gabriel, C; Gaetani, S; Giovine, A; Laloux, C; Maccari, S; Mairesse, J; Malagodi, M; Mazzetta, A; Mennuni, G; Mocaër, E; Morley-Fletcher, S; Nicoletti, F; Silletti, V; van Camp, G; van Reeth, O; Zuena, AR1
Hauser, J; Lange, KM; Lange, KW; Tucha, L; Tucha, O1
Acuña-Castroviejo, D; Lauterbach, EC; Othman, Z; Srinivasan, V; Zakaria, R1
Ponsford, J; Rajaratnam, SM; Sinclair, KL1
Lam, RW1
Steinhilber, D1
Alvarez, E; Guilleminault, C; Lemoine, P1
Armstrong, SM; Guardiola-Lemaitre, B; McNulty, OM; Redman, JR1

Reviews

17 review(s) available for s20098 and Long Sleeper Syndrome

ArticleYear
Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.
    International journal of molecular sciences, 2014, Sep-09, Volume: 15, Issue:9

    Topics: Acetamides; Animals; Benzofurans; Clinical Trials as Topic; Cyclopropanes; Humans; Hypnotics and Sedatives; Indenes; Melatonin; Neurodegenerative Diseases; Receptors, Melatonin; Sleep Wake Disorders

2014
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression.
    International journal of molecular sciences, 2015, Jan-05, Volume: 16, Issue:1

    Topics: Acetamides; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Fibromyalgia; Humans; Migraine Disorders; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Receptor, Serotonin, 5-HT2C; Schizophrenia; Sleep Wake Disorders

2015
The use of agomelatine in OCD: effects on the motivational aspects and dysregulated circadian rhythms.
    Expert opinion on investigational drugs, 2015, Volume: 24, Issue:5

    Topics: Acetamides; Animals; Bipolar Disorder; Chronobiology Disorders; Humans; Hypnotics and Sedatives; Motivation; Obsessive-Compulsive Disorder; Sleep Wake Disorders; Treatment Outcome

2015
Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders.
    Pharmacotherapy, 2016, Volume: 36, Issue:9

    Topics: Acetamides; Benzofurans; Circadian Rhythm; Cyclopropanes; Dietary Supplements; Humans; Receptors, Melatonin; Sleep Wake Disorders

2016
Pathophysiology of depression: role of sleep and the melatonergic system.
    Psychiatry research, 2009, Feb-28, Volume: 165, Issue:3

    Topics: Acetamides; Antidepressive Agents; Circadian Rhythm; Depression; Humans; Melatonin; Prevalence; Receptors, Melatonin; Sleep; Sleep Stages; Sleep Wake Disorders; Suprachiasmatic Nucleus; Wakefulness

2009
Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine.
    Progress in neurobiology, 2009, Volume: 88, Issue:4

    Topics: Acetamides; Animals; Brain; Chronobiology Disorders; Circadian Rhythm; Depressive Disorder, Major; Humans; Hypnotics and Sedatives; Melatonin; Sleep; Sleep Wake Disorders

2009
Agomelatine: innovative pharmacological approach in depression.
    CNS drugs, 2009, Volume: 23 Suppl 2

    Topics: Acetamides; Animals; Antidepressive Agents; Circadian Rhythm; Depressive Disorder, Major; Disease Models, Animal; Humans; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Serotonin 5-HT2 Receptor Antagonists; Sleep Wake Disorders

2009
Agomelatine: efficacy at each phase of antidepressant treatment.
    CNS drugs, 2009, Volume: 23 Suppl 2

    Topics: Acetamides; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder, Major; Humans; Psychiatric Status Rating Scales; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Recurrence; Serotonin 5-HT2 Receptor Antagonists; Sleep Wake Disorders

2009
[Depression as chronobiological illness].
    Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2009, Volume: 11, Issue:2

    Topics: Acetamides; Affect; Biological Clocks; Chronotherapy; Circadian Rhythm; Depression; Depressive Disorder, Major; Humans; Hypnotics and Sedatives; Melatonin; Mood Disorders; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Sleep; Sleep Deprivation; Sleep Wake Disorders; Suprachiasmatic Nucleus

2009
Sleep disturbances: core symptoms of major depressive disorder rather than associated or comorbid disorders.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:4

    Topics: Acetamides; Adrenergic alpha-Antagonists; Anticonvulsants; Antidepressive Agents; Comorbidity; Depressive Disorder, Major; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Secondary Prevention; Sleep Initiation and Maintenance Disorders; Sleep Stages; Sleep Wake Disorders; Sleep, REM

2009
Agomelatine: a novel pharmacological approach to treating depression.
    Drugs of today (Barcelona, Spain : 1998), 2009, Volume: 45, Issue:8

    Topics: Acetamides; Animals; Antidepressive Agents; Anxiety; Depressive Disorder, Major; Drug Interactions; Humans; Melatonin; Secondary Prevention; Sleep Wake Disorders; Substance Withdrawal Syndrome

2009
Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients.
    Human psychopharmacology, 2010, Volume: 25, Issue:3

    Topics: Acetamides; Animals; Antidepressive Agents; Depressive Disorder, Major; Humans; Melatonin; Randomized Controlled Trials as Topic; Sleep Disorders, Circadian Rhythm; Sleep Wake Disorders

2010
Agomelatine for major depressive episodes.
    Drug and therapeutics bulletin, 2010, Volume: 48, Issue:8

    Topics: Acetamides; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Humans; Randomized Controlled Trials as Topic; Secondary Prevention; Sexual Dysfunction, Physiological; Sleep Wake Disorders; Treatment Outcome

2010
Circadian rhythms in obsessive-compulsive disorder.
    Journal of neural transmission (Vienna, Austria : 1996), 2012, Volume: 119, Issue:10

    Topics: Acetamides; Animals; Chronobiology Disorders; Hormones; Humans; Hypnotics and Sedatives; Obsessive-Compulsive Disorder; Sleep Wake Disorders

2012
Agomelatine in depressive disorders: its novel mechanisms of action.
    The Journal of neuropsychiatry and clinical neurosciences, 2012,Summer, Volume: 24, Issue:3

    Topics: Acetamides; Animals; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Disease Models, Animal; Humans; Melatonin; Receptors, Melatonin; Sleep Wake Disorders

2012
Sleep disturbances and depression: a challenge for antidepressants.
    International clinical psychopharmacology, 2006, Volume: 21 Suppl 1

    Topics: Acetamides; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder, Major; Drugs, Investigational; Electroencephalography; Humans; Sleep Wake Disorders; Treatment Outcome

2006
[Melatonin, melatonin receptor agonists and tryptophan as sleep aids].
    Pharmazie in unserer Zeit, 2007, Volume: 36, Issue:3

    Topics: Acetamides; Animals; Antioxidants; Humans; Hypnotics and Sedatives; Indenes; Melatonin; Receptors, Melatonin; Sleep Wake Disorders; Tryptophan

2007

Trials

2 trial(s) available for s20098 and Long Sleeper Syndrome

ArticleYear
Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability.
    Journal of psychopharmacology (Oxford, England), 2019, Volume: 33, Issue:11

    Topics: Acetamides; Adult; Autism Spectrum Disorder; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Intellectual Disability; Male; Middle Aged; Sleep Wake Disorders; Time Factors; Young Adult

2019
Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine.
    The Journal of clinical psychiatry, 2007, Volume: 68, Issue:11

    Topics: Acetamides; Adolescent; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prevalence; Sleep; Sleep Wake Disorders; Surveys and Questionnaires; Venlafaxine Hydrochloride

2007

Other Studies

8 other study(ies) available for s20098 and Long Sleeper Syndrome

ArticleYear
The effect of agomelatine and melatonin on sleep-related eating: a case report.
    Journal of medical case reports, 2017, Sep-28, Volume: 11, Issue:1

    Topics: Acetamides; Central Nervous System Depressants; Depressive Disorder, Major; Female; Humans; Melatonin; Middle Aged; Night Eating Syndrome; Panic Disorder; Patient Compliance; Sleep Wake Disorders; Treatment Outcome; Weight Gain

2017
Treatment of severe sleep disorder related to alcohol-dependence with high-dose agomelatine - a case report.
    Psychiatria Danubina, 2013, Volume: 25, Issue:4

    Topics: Acetamides; Aged; Alcoholism; Humans; Hypnotics and Sedatives; Male; Sleep Wake Disorders; Treatment Outcome

2013
Agomelatine for Depression in Parkinson Disease: Additional Effect on Sleep and Motor Dysfunction.
    Journal of clinical psychopharmacology, 2015, Volume: 35, Issue:6

    Topics: Acetamides; Aged; Aged, 80 and over; Depression; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Sleep Wake Disorders

2015
[Clinical experiences with agomelatine. The inner ear has to be synchronized again].
    MMW Fortschritte der Medizin, 2010, Mar-11, Volume: 152, Issue:10

    Topics: Acetamides; Antidepressive Agents; Circadian Rhythm; Controlled Clinical Trials as Topic; Depression; Ear, Inner; Humans; Hypnotics and Sedatives; Melatonin; Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Wake Disorders; Tranquilizing Agents

2010
Publication bias and outcome reporting bias: agomelatine as a case example.
    Journal of psychosocial nursing and mental health services, 2011, Volume: 49, Issue:9

    Topics: Acetamides; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Humans; Publication Bias; Sexual Dysfunction, Physiological; Sleep Wake Disorders

2011
Chronic agomelatine treatment corrects the abnormalities in the circadian rhythm of motor activity and sleep/wake cycle induced by prenatal restraint stress in adult rats.
    The international journal of neuropsychopharmacology, 2013, Volume: 16, Issue:2

    Topics: Acetamides; Analysis of Variance; Animals; Animals, Newborn; Arousal; Autoradiography; Chronobiology Disorders; Disease Models, Animal; Drug Administration Schedule; Electroencephalography; Electromyography; Female; Hippocampus; Hypnotics and Sedatives; Male; Movement Disorders; Pregnancy; Prenatal Exposure Delayed Effects; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Melatonin; Restraint, Physical; Sleep Wake Disorders; Thiophenes

2013
Actigraphic assessment of sleep disturbances following traumatic brain injury.
    Behavioral sleep medicine, 2014, Volume: 12, Issue:1

    Topics: Acetamides; Actigraphy; Adolescent; Adult; Aged; Brain Injuries; Case-Control Studies; Fatigue; Female; Humans; Male; Middle Aged; Self Report; Sleep; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Young Adult

2014
Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS).
    Pharmacology, biochemistry, and behavior, 1993, Volume: 46, Issue:1

    Topics: Acetamides; Animals; Circadian Rhythm; Disease Models, Animal; Hypnotics and Sedatives; Male; Melatonin; Rats; Sleep Wake Disorders

1993